Want to use our logo?

Download the ICS Branding Pack

ICS Background

Dr Michael Louis Guralnick
Medical college of Wisconsin

ICS 2022

Open Discussion Session 22 Open Discussion ePosters 319 Does the type of anesthesia during stage 1 testing for sacral neuromodulation for urge urinary incontinence influence the outcome?

Open Discussion Session 23 Open Discussion ePosters 368 Is The Presence of Stress Urinary Incontinence Associated with Sacral Neuromodulation Outcomes for OAB?

ICS 2020

Podium Short Oral Session 10 Female Lower Urinary Tract Symptoms 150 Is the 50% Improvement Threshold Adequate for Progression to Implantation in Sacral Neuromodulation?

Open Discussion Session 20 ePoster 4 275 Predictive Factors for Recurrent Urinary Tract Infections in Patients with History of Spinal Cord Injury

ICS 2016

Open Discussion Session 27 Open Discussion ePosters 479 PREDICTORS OF LONGTERM SACRAL NERVE STIMULATION FAILURES

Open Discussion Session 27 Open Discussion ePosters 527 THE IMPACT OF MESENTERIC WINDOW CLOSURE AFTER HARVESTING ILEUM FOR GENITOURINARY RECONSTRUCTIVE SURGERY

ICS 2015

Podium Short Oral Session 10 Updates on the Use of Botulinum Toxin 173 Intradetrusor Botulinum Toxin Injections for the Management of Anticholinergic Refractory, Poorly Compliant Neurogenic Bladders

ICS 2014

Podium Poster Session 43 Rehabilitation and Biomechanics 663 Intone: a novel pelvic floor rehabilitation device for urinary incontinence

ICS 2013

Non Discussion Abstract Session 35 Read By Title 712 The Utility of Lower Abdominal Ultrasound During Percutaneous Suprapubic Catheter Placement

ICS 2011

Non Discussion Abstract Session 31 Read by Title 724 Sensory or Motor Responses: Which are more important for predicting the success of sacral neuromodulation for the management of voiding dysfunction?

ICS 2009

Non Discussion Poster Session 32 319 Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity

Non Discussion Poster Session 32 460 Endoscopic Ablation of Hunner’s Lesions in Interstitial Cystitis Patients

Non Discussion Poster Session 32 576 Bladder diary correlations with urodynamics in women with overactive bladder

ICS 2007

Non Discussion Poster Session 17 128 Incomplete Bladder Emptying After Intra-Detrusor Injection of Botulinum Toxin-A

Non Discussion Abstract Session 19 Read By Title 318 The Use of Intra-Detrusor Botulinum Toxin-A in the Elderly

Non Discussion Abstract Session 19 Read By Title 531 Are there differences between women with urge predominant and stress predominant mixed urinary incontinence?

View ICS Member Details

Michael Guralnick

ICS Member

Profession:Urologist
Qualifications:Staff Member
Privacy:
You must be logged in to view this contact
Sign-in to ICS

REFEREED JOURNAL PUBLICATIONS/ORIGINAL PAPERS:

  1. Guralnick ML, Al-Shammari A, Williot PE, Leonard MP. Outcome of hypospadius repair using the tubularized, incised plate urethroplasty. Canadian J Urol 2000; 7:986.
  2. Amundsen CL, Guralnick ML, Webster GD. Variations in strategy for the treatment of urethral obstruction after pubovaginal slings. J Urology 2000; 164:434.
  3. Amundsen CL, Guralnick ML, Webster GD. Use of the Martius labial fat pad as an adjunct in the management of urinary fistulae and urethral obstruction following anti-incontinence procedures. J Pelvic Surg 2000; 6:310.
  4. Guralnick ML, Webster GD. The augmented anastomotic urethroplasty: indications and outcome in 29 patients. J Urology 2001: 165:1496.
  5. Amundsen CL, Guralnick ML, Webster GD. Functional success of vaginal-cuff excision as a technique for transvaginal repair of vesicovaginal fistulae after hysterectomy. J Pelvic Surg 2001; 7:15.
  6. Sudakoff GS, Spinelli KS, Guralnick M, Datta MW. Diverticulum of bladder occluded by transitional cell carcinoma arising from the bladder. Cases of the Day (serial online) ARRS Link Web. April 2002. Available at http://www.arrs.org/edu/cod2001/day
  7. Sudakoff GS, Spinelli KS, Guralnick M. Traumatic disruption of bulbar urethra with fistula to corpus spongiosum. Cases of the Day (serial online) ARRS Link Web. April 2002. Available at http://www.arrs.org/edu/cod2001/day
  8. Guralnick ML, Miller E, Toh K, Webster GD. Transcorporal artificial urinary sphincter (AUS) cuff placement in cases requiring revision for erosion and urethral atrophy. J Urology 2002; 167:2075.
  9. Hollingsworth M, Quiroz F, Guralnick ML. The management of retained Foley catheters. Can J Urol 2004; 11:1749.
  10. Sudakoff GS, Guralnick M, Langenstroer P, Foley WD, Cihlar KL, Shakespear JS, See WA. CT urography of urinary diversions with enhanced CT digital radiography: Preliminary experience. Am J Roentgenology 2004; 184:131.
  11. Milleman M, Langenstroer P, Guralnick ML. Post-void residual urine volumes in women with overactive bladder symptoms. J Urology 2004; 172:1911.
  12. Lewis J, Ng A, O’Connor RC, Guralnick ML. Are there differences between women with urge predominant and stress predominant mixed urinary incontinence. Neurourol Urodyn 2006; 26:204-207
  13. O'Connor RC, Nanigian DK, Patel BN, Guralnick ML, Ellision LM, Stone AR. Artificial urinary sphincter placement in elderly men. Urology 2007; 69:126-8.
  14. Smither AR, Guralnick ML, Davis NB, See WA. Quantifying the natural history of post-radical prostatectomy incontinence using objective pad test data. BMC Urol 2007;7:2.
  15. Guralnick ML, Benouni S, O’Connor RC, Edmiston C. Characteristics of infections in patients undergoing staged implantation for sacral nerve stimulation. Urology 2007; 69:1073-6.
  16. Garg T, Machi G, Guralnick ML and O'Connor RC: Sacral neuromodulation for urinary retention after pelvic plexus injury. Urology 2007; 70:811.
  17. O'Connor RC, Guralnick ML, Byrd GF, Murphy MJ, Sulman A. Case report: endoscopic unroofing of symptomatic peripelvic simple renal cyst. J Endourol 2007; 21:1497.
  18. Payne RA, O’Connor RC, Guralnick ML. Hemiparesis of bladder caused by tethered cord. Can Urol Assoc J 2008; 2:55.
  19. O’Connor RC, Lyon MB, Guralnick ML, Bales GT. Long-term follow-up of single versus double cuff artificial urinary sphincter insertion for the treatment of severe postprostatectomy stress urinary incontinence. Urology 2008;71:90.
  20. Sudakoff GS, Dunn DP, Guralnick ML, Hellman RS, Eastwood D, See WA. Multidetector computerized tomography urography as primary imaging modality for detecting urinary tract neoplasms in patients with asymptomatic hematuria. J Urol 2008; 179: 862.
  21. Pham KN, Guralnick ML and O’Connor RC: Unilateral versus bilateral stage I neuromodulator lead placement for the treatment of refractory voiding dysfunction. Neurourol Urodyn 2008;27(8):779-81.
  22. Harris SE, Guralnick ML and O’Connor RC: Urethral erosion of transobturator male sling. Urology 2009;73(2):443.
  23. Garg T, Guralnick ML, Langenstroer P, See WA, Hieb RA, Rilling WS, Sudakoff GS and O’Connor RC: Resonance® metallic ureteral stents do not successfully treat ureteroenteric strictures in patients with ileal conduits. J Endourol 2009;23(7):1199-201.
  24. Rasmussen NT, Guralnick ML, O'Connor RC. Successful use of sacral neuromodulation after failed bladder augmentation. CUAJ 2009;3(5):E49-50.
  25. Payne R, O’Connor RC, Kressin M, Guralnick ML. Endoscopic ablation of Hunner’s lesions in interstitial cystitis patients. CUAJ 2009;3(6):473.
  26. Guralnick ML, Grimsby G, Liss M, Szabo A, O’Connor RC. Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity. Int Urogynecol J Pelvic Floor Dysfunct 2010;21(3):325-9.
  27. Pham KN, Topp N, Guralnick ML, Koduri S, Newcomer JR, O'Connor RC. Preoperative Valsalva voiding increases the risk of urinary retention after midurethral sling placement. Int Urogynecol J Pelvic Floor Dysfunct 2010; 21:1243-6.
  28. Makovey I, Davis T, Guralnick ML and O’Connor RC: Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability. Neurouol Urodyn 2011;30:1538-40.
  29. Privratsky JR, Almassi N, Guralnick ML, Anderson BJ and O'Connor RC: Outcomes of grafted bulbar urethroplasty in men with class II or III obesity. Urology 2011;78:1420-3.
  30. Davis T, Makovey I, Guralnick ML and O’Connor RC: Sacral neuromodulation outcomes for the treatment of refractory idiopathic detrusor overactivity stratified by indication – lack of anticholinergic efficacy versus intolerability. CUAJ 2012; 10:1-3.
  31. Kuy SR, Codner PA, Guralnick M, Paul J: Combined rectovesicular injuries from low velocity penetrating trauma in an adult. WMJ 2013 ; 112:32-34.
  32. Neff D, Guise A, Guralnick ML, Langenstroer P, See WA, Jacobsohn KM, O'Connor RC. Duloxetine for the treatment of post-prostatectomy stress urinary incontinence. Can Urol Assoc J 2013;7(5-6):E260-2.
  33. Johnson S*, Fiscus G, Sudakoff GS, O'Connor RC, Guralnick ML: The utility of abdominal ultrasound during percutaneous suprapubic catheter placement. Can J Urol 2013; 20(4):6840-3
    *resident working under my mentorship
  34. Pham KN, Sack BS, O'Connor RC, Guralnick ML, Langenstroer P, See WA, Jacobsohn K: V-Loc urethro-intestinal anastomosis during robotic cystectomy with orthotopic urinary diversion. Can Urol Assoc J 2013 Nov;7(11-12):E663-6. doi: 10.5489/cuaj.508.

BOOKS, CHAPTERS, REVIEWS & COMMENTS:

  1. Webster GD, Guralnick ML. The Neurourologic Evaluation. In: Campbell’s Urology, 8th Edition. Edited by: Walsh PC, Retik AB, Vaughan ED, Wein AJ. Philadelphia, W.B. Saunders, 2002, ch. 25, pp. 900-930.

  2. Webster GD, Guralnick ML. Retropubic Suspension Surgery for Female Sphincteric Incontinence. In: Campbell’s Urology, 8th Edition. Edited by: Walsh PC, Retik AB, Vaughan ED, Wein AJ. Philadelphia, W.B. Saunders, 2002, ch. 31, pp. 1140-1150.

  3. Guralnick ML, Webster GD. Reconstruction of Posterior Urethral Disruption. Urol Clin NA, 2002; 29:429.

  4. Guralnick ML, Webster GD. The Augmented Anastomotic Urethroplasty. Atlas of Urol Clin NA, 2003; 11:43.

  5. Guralnick ML, Webster GD. Transcorporal Insertion of AMS800 Artificial Urinary Sphincter. Atlas of Urol Clin NA, 2003; 11:83.

  6. Guralnick ML. Is Reflux Prevention Necessary in Urinary Diversion? In: Urinary Diversion, 2nd Edition. Edited by: Kreder KJ, Stone A. London, Taylor & Francis, 2005, ch 31, pp297-305.

  7. Guralnick ML. Editorial Comment. J Urol, 2006. 175: 1787.

  8. Guralnick ML. Editorial Comment. J Urol, 2007. 177: 207.

  9. Groth T, Guralnick ML, O'Connor RC. Review of female stress urinary incontinence. Minerva Med, 2007; 98:203-9

  10. O’Connor RC and Guralnick ML: Re: Urethral erosion of transobturator male sling. Urology, 73(2): 450, 2009

  11. Guralnick ML, O’Connor RC, See WA. Assessment and management of irritative voiding symptoms. Med Clin N Am, 2011. 95:121-27

  12. Pagoria D, O’Connor RC, Guralnick ML. Antimuscarinic drugs: Review of the cognitive impact when used to treat overactive bladder in elderly patients. Curr Urol Rep 2011 Oct;12(5):351-7.

  13. Guralnick ML, O’Connor RC. Ileal Ureter Replacement. In: Hinman’s Atlas of Urologic Surgery, 3rd Edition. Edited by: Smith JA, Howards SS, McGuire EJ, Preminger GM. Philadelphia, Saunders, 2012, ch 117, pp751-54.

  14. Guralnick ML, O’Connor RC. The Augmented Anastomotic Urethroplasty. In: Advanced Male Urethral and Genital Reconstructive Surgery, 2nd Edition. Edited by: Brandes SB, Morey AF. New York, Humana Press, 2013, ch 15, pp203-17.

VIDEO, SYLLABI, OR OTHER TEACHING/EDUCATIONAL MATERIAL:

  1. Flynn BJ, Webster GD, Guralnick ML. Implantation of the artificial urinary sphincter (AUS) using the transcorporal approach.
    • Video presented at AUA Annual Meeting, Orlando, FL, 2002.

  2. Webster GD, Guralnick ML. The Neurourologic Evaluation. In: Campbell’s Urology Study Guide, 2nd Edition. Edited by: Walsh PC, Retik AB, Vaughan ED, Wein AJ. Philadelphia, W.B. Saunders, 2002, ch. 25, pp. 88-94.

  3. Webster GD, Guralnick ML. Retropubic suspension surgery for female sphincteric incontinence. In: Campbell’s Urology Study Guide, 2nd Edition. Edited by: Walsh PC, Retik AB, Vaughan ED, Wein AJ. Philadelphia, W.B. Saunders, 2002, ch. 31, pp. 121-123.

  4. Stone A, Shaw J, Lavelle J, O’Connor R, Guralnick M. Management of the Complex Neurogenic Bladder Patient: avoiding and troubleshooting complications.
    • Educational course presented at International Continence Society Annual Meeting, Glasgow, Scotland 8/30/2011.

Dr Michael Louis Guralnick declared on the Friday 12th January 2024 that they had the following existing or known future financial relationships or affiliations:

Teladoc Health, Inc

  • Consultant
UP TO DATE!